tetano
Editor, Senior Moderator
World J Clin Cases
. 2023 Dec 26;11(36):8542-8550.
doi: 10.12998/wjcc.v11.i36.8542. Spinal cord infarction attributed to SARS-CoV-2, with post-acute sequelae of COVID-19: A case report
Christina V Oleson[SUP] 1 [/SUP], Andrew C Olsen[SUP] 2 [/SUP], Suzanna Shermon[SUP] 2 [/SUP]
Affiliations
Background: While stroke and lower extremity venous thromboemboli have been commonly reported following acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spinal cord infarction or ischemia has been extremely rare. Findings of long coronavirus disease (COVID) in this select population have not been studied.
Case summary: We present the case of a 70-year-old female with sudden onset of trunk and lower extremity sensorimotor loss due to spinal cord infarction, attributed to acute infection with SARS-CoV-2. Diagnostic work up confirmed a T3 complete (ASIA impairment Scale A) paraplegia resulting from a thrombotic infarct. Her reported myalgias, neuropathic pain, spasticity, bladder spasms, and urinary tract infections exceeded the frequency and severity of many spinal cord injury (SCI) individuals of similar age and degree of neurologic impairment. In her first year after contracting COVID-19, she underwent 2 separate inpatient rehabilitation courses, but also required acute hospitalization 6 additional times for subsequent infections or uncontrolled pain. Yet other complications of complete non-traumatic SCI (NTSCI), including neurogenic bowel and temperature hypersensitivity, were mild, and pressure injuries were absent. She has now transitioned from the acute to chronic phase of spinal cord injury care, with subsequent development of post-acute sequelae of SARS-CoV-2 infection (PASC).
Conclusion: This individual experienced significant challenges with the combined effects of acute T3 NTSCI and acute COVID-19, with subsequent progression to PASC.
Keywords: COVID-19; Case report; Long COVID; Paraplegia; Post-acute sequelae of SARS-CoV-2 infection; SARS-CoV-2; Spinal cord infarction.
. 2023 Dec 26;11(36):8542-8550.
doi: 10.12998/wjcc.v11.i36.8542. Spinal cord infarction attributed to SARS-CoV-2, with post-acute sequelae of COVID-19: A case report
Christina V Oleson[SUP] 1 [/SUP], Andrew C Olsen[SUP] 2 [/SUP], Suzanna Shermon[SUP] 2 [/SUP]
Affiliations
- PMID: 38188200
- PMCID: PMC10768511
- DOI: 10.12998/wjcc.v11.i36.8542
Background: While stroke and lower extremity venous thromboemboli have been commonly reported following acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spinal cord infarction or ischemia has been extremely rare. Findings of long coronavirus disease (COVID) in this select population have not been studied.
Case summary: We present the case of a 70-year-old female with sudden onset of trunk and lower extremity sensorimotor loss due to spinal cord infarction, attributed to acute infection with SARS-CoV-2. Diagnostic work up confirmed a T3 complete (ASIA impairment Scale A) paraplegia resulting from a thrombotic infarct. Her reported myalgias, neuropathic pain, spasticity, bladder spasms, and urinary tract infections exceeded the frequency and severity of many spinal cord injury (SCI) individuals of similar age and degree of neurologic impairment. In her first year after contracting COVID-19, she underwent 2 separate inpatient rehabilitation courses, but also required acute hospitalization 6 additional times for subsequent infections or uncontrolled pain. Yet other complications of complete non-traumatic SCI (NTSCI), including neurogenic bowel and temperature hypersensitivity, were mild, and pressure injuries were absent. She has now transitioned from the acute to chronic phase of spinal cord injury care, with subsequent development of post-acute sequelae of SARS-CoV-2 infection (PASC).
Conclusion: This individual experienced significant challenges with the combined effects of acute T3 NTSCI and acute COVID-19, with subsequent progression to PASC.
Keywords: COVID-19; Case report; Long COVID; Paraplegia; Post-acute sequelae of SARS-CoV-2 infection; SARS-CoV-2; Spinal cord infarction.
